Triohale Rotacaps Capsules, Strength: 400 mcg

Triohal Rotacaps contain a combination of three active ingredients: Ciclesonide (400mcg), Formoterol (12mcg), and Tiotropium (18mcg). It is used as a maintenance treatment for chronic obstructive pulmonary disease (COPD) and asthma.

Inhalation Medication: Triohal Rotacaps are designed for inhalation use and are used with a suitable inhaler device. The Rotacaps contain the medications in a powdered form for easy inhalation.
Ciclesonide: Ciclesonide is a corticosteroid and an anti-inflammatory medication. It helps to reduce inflammation and swelling in the airways, thus providing relief from symptoms associated with COPD and asthma.
Formoterol: Formoterol is a long-acting beta-agonist bronchodilator. It acts on the beta-2 receptors in the smooth muscles of the airways, causing relaxation and widening of the air passages.
Tiotropium: Tiotropium is a long-acting anticholinergic bronchodilator. It works by blocking the action of acetylcholine, a neurotransmitter that causes smooth muscle constriction in the airways.
Indications: Triohal Rotacaps are primarily prescribed for individuals with COPD and asthma to manage chronic respiratory symptoms and prevent bronchospasm.
Maintenance Treatment: Triohal Rotacaps are used as a maintenance therapy to be used on a regular basis to control chronic respiratory symptoms.
Dosage and Administration: The dosage of Triohal Rotacaps and the frequency of inhalation will be determined by the prescribing healthcare professional based on the individual's condition and response to treatment. It is crucial to follow the prescribed dosage and administration instructions provided by a healthcare professional or the product packaging.
Precautions and Side Effects: As with any medication, Triohal Rotacaps may cause side effects, such as dry mouth, throat irritation, headache, and tremors. It is essential to report any unusual or severe side effects to a healthcare professional.
Inhalation Technique: Proper inhalation technique is essential to ensure that the medication reaches the lungs effectively. Patients should be instructed on the correct use of the inhaler device and Rotacaps.
Please note that the information provided here is a general overview. The use of Triohal Rotacaps should be done under the guidance of a healthcare professional experienced in the management of COPD and asthma. Individual dosing and treatment plans are based on specific medical assessments, and patients should discuss their unique respiratory health needs with their healthcare provider before starting any maintenance therapy.